News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Cristina Solis-Pomales

Articles by Cristina Solis-Pomales

45 Application of the 7-Gene Biosignature in Palpable Versus Nonpalpable Ductal Carcinoma In Situ in a Black Patient Population: Does Palpability Suggest a More Aggressive Genomic Risk?

ByAmy Jeng,Cristina Solis-Pomales,Kseniya Roudakova,J. Jamie Alberty-Oller

May 26th 2024

62 The Impact of Genomic Assays on Breast Cancer Systemic Therapy Treatment Decisions in a Mostly Black Patient Population

ByKseniya Roudakova,Cristina Solis-Pomales,Amy Jeng,J. Jaime Alberty-Oller

May 9th 2024

Latest Updated Articles

45 Application of the 7-Gene Biosignature in Palpable Versus Nonpalpable Ductal Carcinoma In Situ in a Black Patient Population: Does Palpability Suggest a More Aggressive Genomic Risk?
Published: May 26th 2024 | Updated:

Trending on CancerNetwork

FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma

Neoadjuvant Nivolumab/Ipilimumab Shows Superior EFS in Resectable Melanoma

How Will the Continued Success of ADCs in Breast Cancer Be Propelled in the Future?

How ADCs are Replacing Chemotherapy as Breast Cancer Treatment

Trial Assessing Savolitinib/Osimertinib in NSCLC Completes Enrollment

© 2025 MJH Life Sciences^®

All rights reserved.